📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status (2016)

First Author: Weitsman G

Attributed to: King’s College London Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.9963

PubMed Identifier: 27618787

Publication URI: http://europepmc.org/abstract/MED/27618787

Type: Journal Article/Review

Parent Publication: Oncotarget

Issue: 32

ISSN: 1949-2553